0874.HK Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 май 2024 @ 11:08):

Stats
Объем за сегодня	218 000
Средний объем	775 945
Рыночная капитализация	51.97B
EPS	HKD0.600 ( 2023-10-30 )
Last Dividend	HKD0.813 ( 2023-06-14 )
Next Dividend	HKD0 ( N/A )
P/E	7.82
ATR14	HKD0.0490 (0.23%)

Объем Корреляция

Длинно: 0.02 (neutral)

Кратко: 0.07 (neutral)

Signal:(59.069) Neutral

Guangzhou Baiyunshan Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Guangzhou Baiyunshan Корреляция - Валюта/Сырье

-0.58
( weak negative )

-0.61
( weak negative )

0.00
( neutral )

-0.71
( moderate negative )

0.20
( neutral )

0.66
( moderate )

Guangzhou Baiyunshan Финансовые показатели

Annual	2023
Выручка:	HKD75.52B
Валовая прибыль:	HKD14.19B (18.79 %)
EPS:	HKD2.50

FY	2023
Выручка:	HKD75.52B
Валовая прибыль:	HKD14.19B (18.79 %)
EPS:	HKD2.50

FY	2022
Выручка:	HKD70.79B
Валовая прибыль:	HKD13.28B (18.76 %)
EPS:	HKD2.44

FY	2021
Выручка:	HKD69.01B
Валовая прибыль:	HKD13.23B (19.17 %)
EPS:	HKD2.29

Financial Reports:

No articles found.

Guangzhou Baiyunshan Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.813 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Guangzhou Baiyunshan Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.73 - Stable (5.39%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.0300	2000-04-20
Last Dividend	HKD0.813	2023-06-14
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	25	--
Total Paid Out	HKD6.04	--
Avg. Dividend % Per Year	0.00%	--
Score	3.2	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.73
Div. Directional Score	8.17	--

Next Divdend (Est)
(2025-02-21)

HKD0.870 Estimate 3.15 %

Dividend Stability

0.25 Very Poor

Dividend Score

3.20

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
2888.HK	Ex Dividend Junior	2023-08-10	Annually	0.00%
1503.HK	Ex Dividend Junior	2023-09-13	Semi-Annually	0.00%
0552.HK	Ex Dividend Junior	2023-07-03	Annually	0.00%
8223.HK	Ex Dividend Junior	2023-06-08	Annually	0.00%
2009.HK	Ex Dividend Junior	2023-05-18	Annually	0.00%
1083.HK	Ex Dividend Junior	2023-05-30	Annually	0.00%
0151.HK	Ex Dividend Knight	2023-08-24	Semi-Annually	0.00%
3709.HK	Ex Dividend Knight	2023-06-14	Annually	0.00%
1651.HK	Ex Dividend Knight	2023-08-22	Semi-Annually	0.00%
0688.HK	Ex Dividend Knight	2023-09-18	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0534	1.500	8.93	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0522	1.200	8.26	9.91	[0 - 0.3]
returnOnEquityTTM	0.117	1.500	9.81	10.00	[0.1 - 1]
payoutRatioTTM	0.383	-1.000	6.17	-6.17	[0 - 1]
currentRatioTTM	1.640	0.800	6.80	5.44	[1 - 3]
quickRatioTTM	1.302	0.800	7.05	5.64	[0.8 - 2.5]
cashRatioTTM	0.579	1.500	7.89	10.00	[0.2 - 2]
debtRatioTTM	0.175	-1.500	7.08	-10.00	[0 - 0.6]
interestCoverageTTM	11.84	1.000	6.73	6.73	[3 - 30]
operatingCashFlowPerShareTTM	2.34	2.00	9.22	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.286	2.00	9.36	10.00	[0 - 20]
debtEquityRatioTTM	0.374	-1.500	8.50	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.185	1.000	-0.246	-0.246	[0.2 - 0.8]
operatingProfitMarginTTM	0.0679	1.000	-0.641	-0.641	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.276	1.000	9.58	9.58	[0.2 - 2]
assetTurnoverTTM	0.976	0.800	6.83	5.46	[0.5 - 2]
Total Score				11.62

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	7.82	1.000	9.31	0	[1 - 100]
returnOnEquityTTM	0.117	2.50	9.88	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.286	2.00	9.57	10.00	[0 - 30]
dividendYielPercentageTTM	4.12	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	2.34	2.00	9.22	10.00	[0 - 30]
payoutRatioTTM	0.383	1.500	6.17	-6.17	[0 - 1]
pegRatioTTM	-0.973	1.500	-9.82	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0495	1.000	-1.262	0	[0.1 - 0.5]
Total Score				4.73

Guangzhou Baiyunshan

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People's Republic of China and internationally. The company operates through four segments: Great Southern TCM, Great Commerce, Great Health, and Others. It is also involved in the wholesale, retail, import, and export of Western and Chinese medicines, and medical apparatus and instruments; and research and development, production, and sale of beverages, food, healthcare products, pre-packaging food, dairy products, tablets, capsules, lozenges, injections, tortoise herb jelly, etc. In addition, the company invests in health industry, such as medical care, health management, health preservation, elderly care, etc.; and provides commercial and advertising services. As of December 31, 2021, it had 154 retail chain pharmacy outlets, which included 22 Cai Zhi Lin pharmacy outlets, 36 Jian Min pharmacy outlets, 51 GPC Prescription Pharmacy outlets, and 23 Hainan Guangyao Chenfei Pharmaceutical Chain Co., Ltd outlets, as well as 22 retail stores. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China.